|... surface. Most protocols use single agents (
|Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo
Cohen, Mark S.; Al-kasspooles, Mazin F.; Williamson, Stephen K.; Henry, David; Broward, Melinda; Roby, Katherine F.
|C or oxaliplatin) provided IP. ...
|... contrast results using two chemoperfusates:
|Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin
Blackham, Aaron U.; Shen, Perry; Stewart, John H.; Russell, Gregory B.; Levine, Edward A.
|and cisplatin. ...
|... fibroblasts (hTf) to the antimetabolite
|Antifibrotic effects of tocotrienols on human Tenon’s fibroblasts
Antifibrotic effects of tocotrienols on human Tenon’s fibroblasts
Tappeiner, Christoph; Meyenberg, Alexander; Goldblum, David; Mojon, Daniel; Zingg, Jean-Marc; Nesaretnam, Kalanithi; Kilchenmann, Monika; Frueh, Beatrice E.
|... mediated via Fas/FasL-dependent pathway in
|Mitomycin C modulates DNA-double strand break repair genes in cervical carcinoma cells
Mitomycin C modulates DNA-double strand break repair genes in cervical carcinoma cells
Kang, Yun Hee; Lee, Kyung-Ae; Kim, Jung-Hee; Park, Sung-Goo; Yoon, Do-Young
|C-treated cervical carcinoma cells. ...
|... interactions and contraindications
Rochester, Mark A.; Kelly, John D.
|DNA alkylating agent 40 mg in 40 ml sterile ...
|... The chemotherapy protocol consisted of
|Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer
Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer
Vogl, Thomas J.; Naguib, Nagy N. N.; Nour-Eldin, Nour-Eldin A.; Eichler, Katrin; Zangos, Stefan; Gruber-Rouh, Tatjana
|-C only (8 mg/m2; n = 76), ...
|... infancy, trabeculectomy with adjunctive
|Pediatric Glaucoma: Trabeculectomy and Glaucoma Drainage Devices
Pediatric Glaucoma: Trabeculectomy and Glaucoma Drainage Devices
|offers a low chance of success [3, 4, 11]. ...
|... or generate them as described in Generating
|hESC Engineering by Integrase-Mediated Chromosomal Targeting
hESC Engineering by Integrase-Mediated Chromosomal Targeting
Liu, Ying; Lakshmipathy, Uma; Ozgenc, Ali; Thyagarajan, Bhaskar; Lieu, Pauline; Fontes, Andrew; Xue, Haipeng; Scheyhing, Kelly; MacArthur, Chad; Chesnut, Jonathan D.
|C-Treated MEFs. 2. Dulbecco's Modified ...
|... intraperitoneal chemotherapy with
|Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model
Raue, Wieland; Kilian, Maik; Braumann, Chris; Atanassow, Vladimir; Makareinis, Anna; Caldenas, Sonja; Schwenk, Wolfgang; Hartmann, Jens
|or gemcitabine, photodynamic therapy or ...
|... 4. 1X PBS -Ca2+/-Mg2+ (Invitrogen). 5.
|Single Cell Enzymatic Dissociation of Human Embryonic Stem Cells: A Straightforward, Robust, and Standardized Culture Method
Single Cell Enzymatic Dissociation of Human Embryonic Stem Cells: A Straightforward, Robust, and Standardized Culture Method
Ellerström, Catharina; Hyllner, Johan; Strehl, Raimund
|C (Sigma-Aldrich, St. ...
|... endoscopic approach. Topical application of
|Successful treatment of tracheal stenosis by rigid bronchoscopy and topical mitomycin C: a case report
Successful treatment of tracheal stenosis by rigid bronchoscopy and topical mitomycin C: a case report
Wong, Jyi Lin; Tie, Siew Teck; Samril, Bohari; Lum, Chee Lun; Rahman, Mohammad Rizal Abdul; Rahman, Jamalul Azizi Abdul
|C, a potent fibroblast inhibitor reduces ...
|... sensitivity to H2O2, camptothecin, and
|Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin
Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin
Airoldi, Giovanni; Guidarelli, Andrea; Cantoni, Orazio; Panzeri, Chris; Vantaggiato, Chiara; Bonato, Sara; Grazia D’Angelo, Maria; Falcone, Sestina; Palma, Clara; Tonelli, Alessandra; Crimella, Claudia; Bondioni, Sara; Bresolin, Nereo; Clementi, Emilio; Bassi, Maria Teresa
|C, previously found to induce death in ...
|... recommend the routine use of intravesical
|Perioperative Intravesical Therapy
Perioperative Intravesical Therapy
Madeb, Ralph; Messing, Edward
|C after transurethral resection of bladder ...
|... 21 patients ■ Used 30 Gy with one cycle of
Gillis, Amy; Chung, Hans T.; Prasad, Gautam
|+ 5-FU ■ At UCSF with positive microscopic ...
|... cervical cancer has not been reported. 4.4
|Pharmacotherapy Options for Locally Advanced and Advanced Cervical Cancer
Pharmacotherapy Options for Locally Advanced and Advanced Cervical Cancer
Duenãs-González, Alfonso; Cetina, Lucely; Coronel, Jaime; Martínez-Baños, Déborah
|... (LSCD) during treatment with topical
|for primary acquired melanosis with ...
|... frequently recommended concentration of
|C is 2 mg/ml. ...
|... immer die Radiochemotherapie mit 5-FU und
|Humanes Papillomavirus und Analkarzinom
Humanes Papillomavirus und Analkarzinom
Dindo, D.; Riesterer, O.; Weber, A.; Hahnloser, D.
| C Standard. ...
|... resection and then received intravesicular
|[dosage not stated]. ...
|... chemotherapeutic agents such as
|New therapies for non-muscle-invasive bladder cancer
New therapies for non-muscle-invasive bladder cancer
Chiong, Edmund; Esuvaranathan, Kesavan
|C, doxorubicin and thiotepa have been used ...
|... during the first session. E4 Intralesional
|C injection in the treatment of corrosive ...
|... and used very soon after treating with
|In Vitro Neural Differentiation of Human Embryonic Stem Cells Using a Low-Density Mouse Embryonic Fibroblast Feeder Protocol
In Vitro Neural Differentiation of Human Embryonic Stem Cells Using a Low-Density Mouse Embryonic Fibroblast Feeder Protocol
Ozolek, John A.; Jane, Esther P.; Esplen, James E.; Petrosko, Patti; Wehn, Amy K.; Erb, Teresa M.; Mucko, Sara E.; Cote, Lyn C.; Sammak, Paul J.
|C for best results. ...
|... of migration, cells were treated with
|Establishment of Spontaneously Immortalized Keratinocyte Lines from Wild-Type and Mutant Mice
Establishment of Spontaneously Immortalized Keratinocyte Lines from Wild-Type and Mutant Mice
Reichelt, Julia; Haase, Ingo
|C (see Section 3.1.2) to inhibit cell ...
|... (N = 8). Eight patients were treated with
|Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
Levin, Robert D; Daehler, MaryAnn; Grutsch, James F; Hall, John L; Gupta, Digant; Lis, Christopher G
|, which can induce persistent bone marrow ...
|... for chemotherapy-induced nephrotoxicity are
|Acute Kidney Injury in Oncological Disorders and Tumor Lysis Syndrome
Acute Kidney Injury in Oncological Disorders and Tumor Lysis Syndrome
|C, gemcitabine, platinum compounds, ...